Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1834 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Spondylometaphyseal Dysplasia With Cone-rod Dystrophy | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
| SMDCRD | ||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Spondylometaphyseal dysplasia with cone-rod dystrophy (SMDCRD; MIM 608940) is an autosomal recessive chondrodysplasia caused by mutations in the PCYT1A gene. SMDCRD is one of several spondylometaphyseal dysplasias generally characterized by short stature, flat vertebrae and metaphyseal irregularities. SMDCRD can be distinguished from other spondylometaphyseal dysplasias by the presence of progressive visual impairment of variable age of onset due to pigmentary maculopathy and cone-rod dysfunction. Additional features of SMDCRD include severe short stature of post natal onset, moderate platyspondyly with anterior projections in infancy and early childhood, rhizomelia, bowing of the long bones of the legs, metaphyseal cupping and flaring, shortened tubular bones, anterior rib cupping and flaring in children, narrowing of the sciatic notches and horizontal acetabuli with spurs. PCYT1A encodes choline-phosphate cytidylyltransferase A, an enzyme involved in converting phosphocholine into cytidine diphosphate-choline, an intermediate in phosphatidylcholine synthesis. |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| PCYT1A | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 608940 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Ophthalmology, Skeletal Disorders | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.